IL121165A0
(en)
*
|
1997-06-26 |
1997-11-20 |
Yissum Res Dev Co |
Pharmaceutical compositions containing carboxylic acids and derivatives thereof
|
US6180671B1
(en)
*
|
1998-03-10 |
2001-01-30 |
Beth Israel Deaconess Medical Center, Inc. |
Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
|
DE19836339B4
(de)
*
|
1998-08-11 |
2011-12-22 |
N.V. Nutricia |
Kohlenhydratmischung
|
US20090274660A1
(en)
*
|
1999-08-17 |
2009-11-05 |
Immunopath Profile, Inc. |
Pluripotent therapeutic compositions and uses thereof
|
US6495599B2
(en)
*
|
2000-04-13 |
2002-12-17 |
Abbott Laboratories |
Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
|
PT1542670E
(pt)
*
|
2002-09-24 |
2013-07-11 |
Suntory Holdings Ltd |
Composição com efeitos na prevenção do declínio, melhoramento ou aumento de respostas normais de aptidões cognitivas de uma pessoa saudável
|
US7323206B1
(en)
|
2003-03-04 |
2008-01-29 |
B. Braun Medical Inc. |
Reagents and methods for all-in-one total parenteral nutrition for neonates and infants
|
GB0311081D0
(en)
*
|
2003-05-14 |
2003-06-18 |
Btg Internat Limted |
Treatment of neurodegenerative conditions
|
PT1638414E
(pt)
*
|
2003-06-23 |
2009-07-13 |
Nestec Sa |
Fórmula para lactentes ou fórmula de transição
|
EP1643862A1
(en)
*
|
2003-06-24 |
2006-04-12 |
University of Kansas Medical Center |
Infant formula
|
DE112004001520B4
(de)
*
|
2003-08-18 |
2008-04-10 |
Btg International Ltd. |
Verwendung eines Lipidglyzerids festgelegter Struktur zur Herstellung eines Medikamentes zur Behandlung der multiplen Sklerose
|
EP1597978A1
(en)
*
|
2004-05-17 |
2005-11-23 |
Nutricia N.V. |
Synergism of GOS and polyfructose
|
US8252769B2
(en)
|
2004-06-22 |
2012-08-28 |
N. V. Nutricia |
Intestinal barrier integrity
|
EP1721611A1
(en)
*
|
2005-04-21 |
2006-11-15 |
N.V. Nutricia |
Nutritional supplement with oligosaccharides for a category of HIV patients
|
ES2336015T5
(es)
*
|
2004-06-22 |
2014-01-09 |
N.V. Nutricia |
Mejora de la integridad de la barrera intestinal en pacientes de VIH mediante el uso de ácidos grasos
|
US7862808B2
(en)
|
2004-07-01 |
2011-01-04 |
Mead Johnson Nutrition Company |
Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
|
EP1656839A1
(en)
|
2004-11-11 |
2006-05-17 |
N.V. Nutricia |
Nutrition containing lipid blend
|
GB0425932D0
(en)
*
|
2004-11-25 |
2004-12-29 |
Btg Int Ltd |
Structured phospholipids
|
GB0504362D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Cytokine modulators
|
GB0504333D0
(en)
*
|
2005-03-02 |
2005-04-06 |
Btg Int Ltd |
Treatment of cytokine dysregulation
|
US7303745B2
(en)
|
2005-04-15 |
2007-12-04 |
Bristol-Myers Squibb Company |
Method for preventing or treating the development of respiratory allergies
|
US20060233762A1
(en)
*
|
2005-04-15 |
2006-10-19 |
Mcmahon Robert J |
Method for treating or preventing systemic inflammation in formula-fed infants
|
ATE471665T1
(de)
*
|
2005-04-21 |
2010-07-15 |
Nutricia Nv |
Nahrungsergänzungsmittel für hiv-patienten
|
WO2006127620A2
(en)
|
2005-05-23 |
2006-11-30 |
Massachusetts Institute Of Technology |
Compositions containing pufa and methods of use thereof
|
JP2007063219A
(ja)
*
|
2005-09-01 |
2007-03-15 |
Juntendo |
新生児壊死性腸炎疾患予防剤
|
US20070166354A1
(en)
*
|
2005-10-26 |
2007-07-19 |
Bridget Barrett-Reis |
Method of reducing the risk of retinopathy of prematurity in preterm infants
|
US7829126B2
(en)
|
2005-10-26 |
2010-11-09 |
Abbott Laboratories |
Infant formulas containing docosahexaenoic acid and lutein
|
US20070149617A1
(en)
|
2005-11-14 |
2007-06-28 |
Deckelbaum Richard J |
Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
|
AU2006327996B2
(en)
*
|
2005-12-23 |
2012-03-29 |
N.V. Nutricia |
Infant nutritional compositions for preventing obesity
|
US20080003330A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Ricardo Rueda |
Infant formulas for early brain development
|
US20080003329A1
(en)
*
|
2006-06-30 |
2008-01-03 |
Ricardo Rueda |
Enriched infant formulas
|
US7867542B2
(en)
*
|
2006-11-02 |
2011-01-11 |
Ach Food Companies, Inc. |
Non-flammable release composition
|
CN101801200B
(zh)
|
2007-09-17 |
2014-10-29 |
康奈尔大学 |
用于预防或治疗胃肠病症的支链脂肪酸
|
AU2008309140B9
(en)
|
2007-10-09 |
2013-07-04 |
Frutarom Limited |
Lipid compositions for the treatment of gastro-intestinal disorders and the promotion of intestinal development and maturation
|
UY31410A1
(es)
*
|
2007-10-30 |
2009-05-29 |
|
Composicion que comprende acidos grasos poliinsaturados y carbon vegetal activado
|
CN101909467B
(zh)
|
2007-11-01 |
2013-04-24 |
恩兹默泰克有限公司 |
用于婴儿营养的脂质混合物
|
US8361534B2
(en)
*
|
2007-12-20 |
2013-01-29 |
Abbott Laboratories |
Stable nutritional powder
|
MY168206A
(en)
*
|
2007-12-20 |
2018-10-15 |
Abbott Lab |
Stable nutritional powder
|
EP2100897A1
(en)
*
|
2008-01-30 |
2009-09-16 |
BNLfood Investments SARL |
Lecithin based composition and its use in food
|
WO2009096772A1
(en)
*
|
2008-02-01 |
2009-08-06 |
N.V. Nutricia |
Composition for stimulating natural killer cell activity
|
US9737213B1
(en)
*
|
2009-03-24 |
2017-08-22 |
Vioptix, Inc. |
Using an oximeter probe to detect intestinal ischemia
|
AU2010230362B2
(en)
*
|
2009-04-01 |
2015-01-15 |
Société des Produits Nestlé S.A. |
Reduction of risk of obesity
|
TW201112967A
(en)
*
|
2009-09-16 |
2011-04-16 |
Abbott Lab |
Dryblended nutritional powders
|
TW201121431A
(en)
*
|
2009-12-01 |
2011-07-01 |
Abbott Lab |
Soy protein-based nutritional formula with superior stability
|
TWI492744B
(zh)
*
|
2009-12-04 |
2015-07-21 |
Abbott Lab |
使用類胡蘿蔔素調節早產兒發炎症之方法
|
BR112012013766A2
(pt)
*
|
2009-12-08 |
2015-09-15 |
Nestec Sa |
"fórmula infantil com probióticos e componentes de membrana do glóbulo de gordura do leite"
|
DK2525811T4
(en)
*
|
2010-01-19 |
2019-04-08 |
Abbott Lab |
COMPOSITION, INCLUDING LACTOBACILLUS RHAMNOSUS HN001 AND PREBIOTICS FOR USE IN TREATMENT OF ALLERGIC LUNG DISEASE
|
PE20121730A1
(es)
|
2010-01-29 |
2013-01-13 |
Abbott Lab |
Liquidos nutricionales envasados asepticamente que comprenden beta-hidroxi-beta-metilbutirato (hmb)
|
US9693577B2
(en)
|
2010-01-29 |
2017-07-04 |
Abbott Laboratories |
Method of preparing a nutritional powder comprising spray dried HMB
|
ES2481865T3
(es)
|
2010-01-29 |
2014-07-31 |
Abbott Laboratories |
Emulsiones nutricionales que comprenden HMB de calcio
|
TWI526161B
(zh)
|
2010-06-10 |
2016-03-21 |
亞培公司 |
包含鈣hmb及可溶性蛋白質之實質上透明營養液
|
EP2397038A1
(en)
|
2010-06-21 |
2011-12-21 |
Abbott Laboratories |
Early programming of brain function through soy protein feeding
|
WO2012009426A1
(en)
|
2010-07-13 |
2012-01-19 |
Abbott Laboratories |
High tolerance infant formula including hydrolyzed protein
|
EP2422629A1
(en)
|
2010-08-23 |
2012-02-29 |
Abbott Laboratories |
Methods for enhancing cognition and/or memory using maltodextrins
|
JP2013535984A
(ja)
|
2010-08-24 |
2013-09-19 |
アボット・ラボラトリーズ |
官能特性を改善した栄養製品
|
WO2012027287A1
(en)
|
2010-08-24 |
2012-03-01 |
Abbott Laboratories |
Nutritional products including pea protein hydrolysates
|
MY162797A
(en)
|
2010-12-29 |
2017-07-14 |
Abbott Lab |
Nutritional products including a novel fat system including monoglycerides
|
NZ612504A
(en)
|
2010-12-31 |
2015-02-27 |
Abbott Lab |
Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
|
WO2012092160A2
(en)
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Human milk oligosaccharides to promote growth of beneficial bacteria
|
WO2012092157A2
(en)
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
|
MY171620A
(en)
|
2010-12-31 |
2019-10-21 |
Abbott Lab |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers or children using human milk oligosaccharides
|
NZ613180A
(en)
|
2010-12-31 |
2015-02-27 |
Abbott Lab |
Methods of using human milk oligosaccharides for improving airway respiratory health
|
SG191798A1
(en)
|
2010-12-31 |
2013-08-30 |
Abbott Lab |
Synbiotic combination of probiotic and human milk oligosaccharides to promote growth of beneficial microbiota
|
ES2667393T3
(es)
|
2010-12-31 |
2018-05-10 |
Abbott Laboratories |
Oligosacáridos de leche humana para modular inflamación
|
WO2012092153A1
(en)
|
2010-12-31 |
2012-07-05 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof for treating and/or preventing enteric viral infection
|
WO2013012989A2
(en)
|
2011-07-19 |
2013-01-24 |
The Trustees Of Columbia University In The City Of New York |
Method and system for production of hydrogen and carbon monoxide
|
US11446316B2
(en)
|
2011-07-22 |
2022-09-20 |
Abbott Laboratories |
Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
|
CN113662199A
(zh)
|
2011-08-29 |
2021-11-19 |
雅培制药有限公司 |
用于预防胃肠道损伤和/或促进胃肠道愈合的人乳寡糖
|
IN2014DN06139A
(id)
|
2011-12-29 |
2015-08-14 |
Abbott Lab |
|
WO2013101516A1
(en)
|
2011-12-29 |
2013-07-04 |
Abbott Laboratories |
Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using extracted genomic dna
|
MY168661A
(en)
|
2012-03-27 |
2018-11-28 |
Abbott Lab |
Methods for modulating cell-mediated immunity using human milk oligosaccharides
|
WO2013170189A1
(en)
|
2012-05-11 |
2013-11-14 |
Abbott Laboratories |
Combination of beta - hydroxy - beta - methylbutyrate and beta - alanine for increasing muscle blood flow
|
ES2795665T3
(es)
|
2012-09-14 |
2020-11-24 |
Abbott Lab |
Procedimientos para aumentar la funcionalidad cerebral utilizando 2-fucosil-lactosa
|
ES2572831T3
(es)
|
2012-09-14 |
2016-06-02 |
Abbott Laboratories |
Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
|
EP2708146A1
(en)
|
2012-09-17 |
2014-03-19 |
Abbott Laboratories, Inc. |
Nutritional composition for pregnant women with a beneficial glucose and insulin profile
|
WO2014078544A1
(en)
|
2012-11-14 |
2014-05-22 |
Abbott Laboratories |
Compositions and methods for improving the long term safety of powdered infant formulas
|
WO2014099904A1
(en)
|
2012-12-17 |
2014-06-26 |
Abbott Laboratories |
Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
|
WO2014100022A1
(en)
|
2012-12-18 |
2014-06-26 |
Abbott Laboratories |
Dietary oligosaccharides to enhance learning and memory
|
MY187609A
(en)
|
2012-12-18 |
2021-10-04 |
Abbott Lab |
Human milk oligosaccharides to ameliorate symptoms of stress
|
EP2745705A1
(en)
|
2012-12-18 |
2014-06-25 |
Abbott Laboratories |
Nutritional use of human milk oligosaccharides
|
CN110679948A
(zh)
|
2012-12-20 |
2020-01-14 |
雅培制药有限公司 |
使用人乳寡糖用于调节炎症的营养制剂
|
EP2745708A1
(en)
|
2012-12-24 |
2014-06-25 |
Abbott Laboratories, Inc. |
Antidepressant effect of ß-hydroxy-ß-methylbutyrate
|
CN105188416A
(zh)
|
2013-03-12 |
2015-12-23 |
雅培制药有限公司 |
包含多功能粘度调节剂的组合物
|
SG11201507047YA
(en)
|
2013-03-15 |
2015-10-29 |
Abbott Lab |
Nutritional compositions including calcium beta-hydroxy-beta-methylbutyrate, casein phosphopeptide, and protein
|
WO2014144458A1
(en)
|
2013-03-15 |
2014-09-18 |
Abbott Laboratories |
Methods of maintaining and improving muscle function
|
CN105263321B
(zh)
|
2013-03-28 |
2018-07-27 |
哥伦比亚大学纽约管理委员会 |
用omega-3甘油酯再灌注促进对用于移植的供体器官的保护
|
SG11201510147VA
(en)
|
2013-06-10 |
2016-01-28 |
Abbott Lab |
Methods and compositions for enhancing cognitive performance
|
WO2015048646A1
(en)
|
2013-09-30 |
2015-04-02 |
Abbott Laboratories |
Protein powder
|
CN104717891A
(zh)
|
2013-10-11 |
2015-06-17 |
雅培制药有限公司 |
用于孕妇的具有有益葡萄糖和胰岛素特征的营养组合物
|
CN103558296B
(zh)
*
|
2013-10-18 |
2015-03-04 |
中国农业大学 |
一种基于脂肪酸检测的动物源性饲料原料鉴别方法
|
CN104623637A
(zh)
|
2013-11-07 |
2015-05-20 |
健能隆医药技术(上海)有限公司 |
Il-22二聚体在制备静脉注射药物中的应用
|
WO2015077233A1
(en)
|
2013-11-19 |
2015-05-28 |
Abbott Laboratories |
Methods for preventing or mitigating acute allergic responses using human milk oligosaccharides
|
EP2888950A1
(en)
|
2013-12-24 |
2015-07-01 |
Abbott Laboratories |
Methods for treating, preventing, or reducing neuroinflammation or cognitive impairment
|
WO2015105981A2
(en)
|
2014-01-09 |
2015-07-16 |
Abbott Laboratories |
Conditional essentiality of hmb
|
CA3179163A1
(en)
|
2014-04-08 |
2015-10-15 |
Abbott Laboratories |
Methods for enhancing mucosal innate immune responses to and/or detection of pathogens using human milk oligosaccharides
|
DE102015101273A1
(de)
*
|
2015-01-29 |
2016-08-04 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Prophylaxe und Behandlung von frühgeburtlichkeitsassoziierten Entwicklungsstörungen
|
WO2017181143A1
(en)
|
2016-04-15 |
2017-10-19 |
Generon (Shanghai) Corporation, Ltd. |
Use of il-22 in treating necrotizing enterocolitis
|
RU2665947C1
(ru)
*
|
2017-07-13 |
2018-09-05 |
Атикат Магомедхановна Герейханова |
Способ лечения некротического энтероколита
|
CA3141763A1
(en)
|
2019-06-07 |
2020-12-10 |
Abbott Laboratories |
Nutritional ingredient with flow and antifoam properties
|
EP4132560A1
(en)
|
2020-04-06 |
2023-02-15 |
Abbott Laboratories |
Nutritional formulations for modulating respiratory-induced cytokines
|
CN112137998A
(zh)
*
|
2020-10-10 |
2020-12-29 |
上海交通大学医学院附属新华医院 |
一种活性成分在制备防治坏死性小肠结肠炎药物中的应用
|
WO2022177965A1
(en)
|
2021-02-16 |
2022-08-25 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
|
WO2022226311A1
(en)
|
2021-04-23 |
2022-10-27 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and a designed lipid component for improving lung function
|
WO2022266058A1
(en)
|
2021-06-14 |
2022-12-22 |
Abbott Laboratories |
Methods and compositions for treating gas
|
WO2023159093A1
(en)
|
2022-02-16 |
2023-08-24 |
Abbott Laboratories |
Nutritional compositions comprising human milk oligosaccharides and bovine immunoglobulin
|
WO2024064327A1
(en)
|
2022-09-22 |
2024-03-28 |
Abbott Laboratories |
Human milk oligosaccharides for enhancing blood-brain barrier function
|